Patent details

301320 Product Name: autologe anti-CD19-getransduceerde CD3+-cellen (brexucabtagene autoleucel)

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301320
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3102609
Status:
Application Pending
Application number:
301320
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/20/1492
Marketing Authorization Type:
EEA
Marketing Authorization Date:
15/12/2020
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
25/02/2025
First Marketing Authorization date:
15/12/2020
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
26/02/2025
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
25/02/2025
 
 

 

Name:
Kite Pharma, Inc.
Address:
2400 Broadway, 90404, Santa Monica, CA, United States of America (US)

From:
25/02/2025
 
 

 

Name:
The United States of America, as Represented by The Secretary, Department of Health and Human Services
Address:
Office of Technology Transfer National Institutes of Health 6701 Rockledge Drive Suite 700, MSC 7788, 20892-7788, Bethesda, Maryland , United States of America (US)

Agent

Name:
ir. B.Ch. Ledeboer c.s
From:
25/02/2025
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

Bulletin Heading:
SPC
Journal edition number:
10/25
Publication date:
05/03/2025
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
27/02/2025 Outgoing Correspondence Confirmation receipt request 2 PDF /1/8/2/1/9/0801091281/docs/301320_25_645835l174.pdf
25/02/2025 SPC Documents Marketing Authorization SPC 4 PDF /1/8/2/1/9/0801091281/docs/301320_0_supplprotectioncertificate20250226025740285.pdf
25/02/2025 SPC Documents Accompanying letter SPC 3 PDF /1/8/2/1/9/0801091281/docs/301320_1_supplprotectioncertificate20250226025740273.pdf
25/02/2025 SPC Documents Annex SPC 16 PDF /1/8/2/1/9/0801091281/docs/301320_2_supplprotectioncertificate20250226025740311.pdf
25/02/2025 SPC Documents Summary of the characteristics of the product 20 PDF /1/8/2/1/9/0801091281/docs/301320_3_supplprotectioncertificate20250226025740293.pdf
25/02/2025 SPC Documents Annex SPC 4 PDF /1/8/2/1/9/0801091281/docs/301320_4_supplprotectioncertificate20250226025740302.pdf
25/02/2025 SPC Documents Annex SPC 2 PDF /1/8/2/1/9/0801091281/docs/301320_5_supplprotectioncertificate20250226025740320.pdf
25/02/2025 Application Form First filed application form 3 PDF /1/8/2/1/9/0801091281/docs/301320_6_applicationform20250226025740240.pdf
25/02/2025 SPC Documents Annex SPC 6 PDF /1/8/2/1/9/0801091281/docs/301320_7_supplprotectioncertificate20250226030944319.pdf
25/02/2025 SPC Documents Annex SPC 703 PDF /1/8/2/1/9/0801091281/docs/301320_8_supplprotectioncertificate20250226031735788.pdf
25/02/2025 SPC Documents Summary of the characteristics of the product 24 PDF /1/8/2/1/9/0801091281/docs/301320_9_supplprotectioncertificate20250226033205935.pdf
25/02/2025 SPC Documents Annex SPC 4 PDF /1/8/2/1/9/0801091281/docs/301320_10_supplprotectioncertificate20250226033205960.pdf
25/02/2025 SPC Documents Annex SPC 16 PDF /1/8/2/1/9/0801091281/docs/301320_11_supplprotectioncertificate20250226033205980.pdf
25/02/2025 SPC Documents Summary of the characteristics of the product 18 PDF /1/8/2/1/9/0801091281/docs/301320_12_supplprotectioncertificate20250226033900692.pdf
25/02/2025 SPC Documents Annex SPC 4 PDF /1/8/2/1/9/0801091281/docs/301320_13_supplprotectioncertificate20250226033900718.pdf
25/02/2025 SPC Documents Annex SPC 15 PDF /1/8/2/1/9/0801091281/docs/301320_14_supplprotectioncertificate20250226033900727.pdf
25/02/2025 SPC Documents Annex SPC 14 PDF /1/8/2/1/9/0801091281/docs/301320_15_supplprotectioncertificate20250226034003396.pdf
25/02/2025 SPC Documents Marketing Authorization SPC 4 PDF /1/8/2/1/9/0801091281/docs/301320_16_supplprotectioncertificate20250226034053834.pdf
25/02/2025 SPC Documents Annex SPC 18 PDF /1/8/2/1/9/0801091281/docs/301320_17_supplprotectioncertificate20250226034507824.pdf
25/02/2025 SPC Documents Summary of the characteristics of the product 29 PDF /1/8/2/1/9/0801091281/docs/301320_18_supplprotectioncertificate20250226034507791.pdf
25/02/2025 SPC Documents Annex SPC 4 PDF /1/8/2/1/9/0801091281/docs/301320_19_supplprotectioncertificate20250226034507816.pdf
25/02/2025 SPC Documents Annex SPC 127 PDF /1/8/2/1/9/0801091281/docs/301320_20_supplprotectioncertificate20250226033239310.pdf
25/02/2025 SPC Documents Annex SPC 28 PDF /1/8/2/1/9/0801091281/docs/301320_21_supplprotectioncertificate20250226031009237.pdf
25/02/2025 SPC Documents Annex SPC 3 PDF /1/8/2/1/9/0801091281/docs/301320_22_supplprotectioncertificate20250226030916795.pdf
25/02/2025 SPC Documents Annex SPC 131 PDF /1/8/2/1/9/0801091281/docs/301320_23_supplprotectioncertificate20250226030852751.pdf
25/02/2025 SPC Documents Annex SPC 24 PDF /1/8/2/1/9/0801091281/docs/301320_24_supplprotectioncertificate20250226034543478.pdf